About
Valneva Se (NASDAQ:VALN) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 26 2026
Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC
Mar 23 2026
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
Mar 18 2026
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Mar 9 2026
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
Mar 9 2026
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
Financials
Revenue
$174.66 M
Market Cap
$529.95 M
EPS
-1.57